Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Case ReportObservationalManualCurated RecordAugust 18, 2010DOI
Authors (2)
LeadUniversity of Zurich
Franz X. Vollenweider and Michael Kometer are at the Neuropsychopharmacology and Brain Imaging Research Unit, University Hospital of Psychiatry, Zurich, Switzerland.,
MeSH Terms
PsilocybinHallucinogenLysergic acid diethylamideNeurosciencePsychologyMoodMood disordersDissociativeNeuroimagingPsychiatryPsychotherapistPsychedelics and Drug Studies
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders | PsiHub